South African firm to help make Pfizer/BioNTech Covid vaccineBy Agency Staff21 July 2021 Pfizer and BioNTech have struck a deal for South Africa’s Biovac Institute to help manufacture around 100 million doses a year of their Covid-19 vaccine for the African Union.
